Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.50
Bid: 180.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 5.00 (2.778%)
Open: 182.50
High: 182.50
Low: 182.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adoption of Financial Reporting Standard 101

10 Jan 2017 07:00

RNS Number : 7279T
Synectics PLC
10 January 2017
 

 

 

 

10 January 2017

 

Synectics plc

 

Notification to shareholders on parent company financial statements: Adoption of Financial Reporting Standard 101 - Reduced Disclosure Framework

 

Synectics plc (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, announces that following the introduction by the Financial Reporting Council ("FRC") of a new UK Generally Accepted Accounting Practice ("UK GAAP") accounting framework for periods commencing on or after 1 January 2015, there is a requirement to prepare its parent company financial statements for its financial year commencing 1 December 2015 on one of the new bases permitted by the FRC.

 

The financial statements for the year ended 30 November 2015 of Synectics plc (the "Company"), as set out on pages 78 to 86 of the 2015 Annual Report, were prepared in accordance with UK GAAP. The 2015 Annual Report is available on the Company's website, www.synecticsplc.com.

 

The Company proposes to adopt FRS 101 "Reduced Disclosure Framework" and to take advantage of the permitted election to the disclosure exemptions allowed under FRS 101 for the year ended 30 November 2016 and thereafter. As a result of taking the available disclosure exemptions permitted under FRS 101, disclosures are expected to follow closely those reported under UK GAAP.

 

The Company's decision to adopt FRS 101 does not require shareholder approval. However, due to the election to take the available disclosure exemptions permitted under FRS 101, the Company is required to notify all shareholders of this election and any shareholder or shareholders holding in aggregate 5 per cent. or more of the total allotted shares in the Company may object. Objections must be served in writing and be delivered to the Company Secretary at the Company's registered office at Studley Point, 88 Birmingham Road, Studley, Warwickshire B80 7AS not later than Tuesday 7 February 2017. A letter will be sent to the Company's shareholders later today.

 

The consolidated financial statements of the Company and its subsidiaries will continue to be prepared in accordance with IFRS as adopted by the EU.

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

Paul Webb, Chief Executive

Mike Stilwell, Finance Director

www.synecticsplc.com

email: info@synecticsplc.com

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths / Henry Willcocks

Media enquiries:

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Jane Glover

email: synectics@buchanan.uk.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGGMNLLGNZM
Date   Source Headline
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results
8th Mar 20077:00 amRNSHolding(s) in Company
20th Feb 200712:33 pmRNSGrant of Options
7th Feb 20077:02 amRNSNorth American Contract Wins
7th Feb 20077:02 amRNSInterim Results
6th Feb 200710:14 amRNSDirector/PDMR Shareholding
5th Feb 20077:00 amRNSDirectorate Change
29th Jan 20072:58 pmRNSNotice of Results
26th Jan 20077:01 amRNSTrading Update
28th Dec 20064:36 pmRNSGrant of Options
22nd Dec 20069:37 amRNSTotal Voting Rights & Capital
5th Dec 20067:01 amRNSInterim Results
29th Nov 20063:25 pmRNSDirector/PDMR Shareholding
24th Nov 200611:53 amRNSNotice of Results
24th Oct 20067:01 amRNSAcquisition
4th Oct 20067:00 amRNSTrading Statement
18th Sep 20069:11 amRNSDirectorate Change
13th Jul 20067:01 amRNSIssue of Equity
20th Jun 200610:39 amRNSGrant of Options
14th Jun 20065:06 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.